Spatial localization of elevated Lac and Lip levels compared with morphologic abnormalities after surgery
Patient | Pathology | Elevated Lac | Elevated Lip | ||||
---|---|---|---|---|---|---|---|
Resection Cavity | CE | T2-CE | Resection Cavity | CE | T2-CE | ||
7* | OD2 | No | No | No | No | No | No |
8 | A2 | No | No | No | No | No | No |
9 | A2 | No | No | No | No | No | No |
10 | OD2 | No | No | No | No | No | No |
11 | OD2 | No | No | No | No | No | Yes |
12 | OD2 | No | No | No | Yes | No | No |
13 | OA2 | No | No | Yes | No | No | No |
14 | OA2 | No | No | No | No | No | No |
15 | A2 | Yes | No | No | Yes | Yes | No |
16 | A2 | Yes | Yes | Yes | Yes | No | No |
17 | A2 | No | No | Yes | No | No | Yes |
21* | AA3 | No | No | No | No | No | No |
22* | OD3 | No | No | No | No | No | No |
26* | GBM | Yes | No | No | Yes | No | No |
27* | GBM | Yes | No | No | No | No | No |
28* | GBM | Yes | Yes | Yes | Yes | Yes | No |
29* | GBM | No | No | No | Yes | No | No |
30* | GBM | No | No | No | No | No | No |
31* | GBM | Yes | No | No | No | No | No |
32* | GBM | Yes | No | No | No | No | No |
33* | GBM | Yes | No | No | No | No | No |
34 | GBM | No | Yes | No | No | Yes | No |
35 | GBM | Yes | Yes | Yes | Yes | Yes | No |
36 | GBM | No | No | No | No | No | No |
37 | GBM | Yes | No | No | Yes | Yes | No |
38 | GBM | Yes | No | No | No | Yes | No |
39 | GBM | Yes | Yes | No | No | No | No |
Note.—Data after surgical resection or biopsy but before radiation treatment or chemotherapy. CE indicates contrast enhancement; T2-CE, regions within T2 hyperintensity but outside contrast enhancement; A2, grade-II astrocytomas; OA2, grade-II oligoastrocytomas; OD2, grade-II oligodendrogliomas; AA3, grade-III anaplastic astrocytomas; OA3, grade-III oligoastrocytomas; OD3, grade-III oligodendrogliomas.
* Patients with both presurgical and postsurgical data.